Search Results
CD30 and Tumor Progression in Hodgkin Lymphoma
Dr. Zelenetz Discusses CD30 as a Target in Lymphoma
CD30, a promising target for CAR-T therapy in Hodgkin lymphoma
Targeting CD30 in Classical Hodgkin Lymphoma
Dual-targeting CD30/PDL1 CAR-T therapy in Hodgkin lymphoma
CD30-Specific CAR T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma
Infusion of CD30 CAR T-cells following AuHCT in patients with lymphoma
‘Off-the-shelf’ EBV-specific CAR-T cells for Hodgkin lymphoma
Treating Patients With CD30-Positive PTCL
CD30-directed CAR-Ts co-expressing CCR4 in R/R HL and CD30+ CTCL
Is CD30 an accurate diagnostic marker in lymphomas other than Hodgkin lymphoma?
CD30 cell graphs of Hodgkin lymphoma are not scale-free—an... - Tim Schäfer - Highlights - ISMB 2016
